Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 3
1979 2
1981 1
1983 1
1984 1
1985 2
1989 1
1990 2
1991 3
1992 1
1993 1
1994 1
1995 2
1996 3
1997 1
1999 1
2000 3
2001 6
2002 3
2003 6
2005 2
2006 3
2007 1
2008 1
2010 4
2011 3
2012 1
2013 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Vergote I, Tropé CG, Amant F, Kristensen GB, Ehlen T, Johnson N, Verheijen RH, van der Burg ME, Lacave AJ, Panici PB, Kenter GG, Casado A, Mendiola C, Coens C, Verleye L, Stuart GC, Pecorelli S, Reed NS; European Organization for Research and Treatment of Cancer-Gynaecological Cancer Group; NCIC Clinical Trials Group. Vergote I, et al. Among authors: lacave aj. N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806. N Engl J Med. 2010. PMID: 20818904 Free article. Clinical Trial.
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
Pfisterer J, Plante M, Vergote I, du Bois A, Hirte H, Lacave AJ, Wagner U, Stähle A, Stuart G, Kimmig R, Olbricht S, Le T, Emerich J, Kuhn W, Bentley J, Jackisch C, Lück HJ, Rochon J, Zimmermann AH, Eisenhauer E; AGO-OVAR; NCIC CTG; EORTC GCG. Pfisterer J, et al. Among authors: lacave aj. J Clin Oncol. 2006 Oct 10;24(29):4699-707. doi: 10.1200/JCO.2006.06.0913. Epub 2006 Sep 11. J Clin Oncol. 2006. PMID: 16966687 Clinical Trial.
Chemotherapy for ovarian cancer.
Lacave AJ, Peláez I, Palacio I. Lacave AJ, et al. N Engl J Med. 1996 May 9;334(19):1269-70. N Engl J Med. 1996. PMID: 8606731 No abstract available.
Phase I trial of intermittent high-dose dacarbazine.
Buesa JM, Gracia M, Valle M, Estrada E, Hidalgo OF, Lacave AJ. Buesa JM, et al. Among authors: lacave aj. Cancer Treat Rep. 1984 Mar;68(3):499-504. Cancer Treat Rep. 1984. PMID: 6704980
Phase II trial of epirubicin at standard dose in relapsed ovarian cancer.
Peláez I, Lacave AJ, Palacio I, Alvarez E, Cueva JF, Muñiz I, Arranz F, Fra J. Peláez I, et al. Among authors: lacave aj. Eur J Cancer. 1996 May;32A(5):899-900. doi: 10.1016/0959-8049(96)00003-2. Eur J Cancer. 1996. PMID: 9081375 Clinical Trial. No abstract available.
58 results